• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PRECISION-Panc: the Next Generation Therapeutic Development Platform for Pancreatic Cancer.

作者信息

Dreyer S B, Jamieson N B, Cooke S L, Valle J W, McKay C J, Biankin A V, Chang D K

机构信息

Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK.

Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.

出版信息

Clin Oncol (R Coll Radiol). 2020 Jan;32(1):1-4. doi: 10.1016/j.clon.2019.07.011. Epub 2019 Aug 2.

DOI:10.1016/j.clon.2019.07.011
PMID:31378449
Abstract
摘要

相似文献

1
PRECISION-Panc: the Next Generation Therapeutic Development Platform for Pancreatic Cancer.PRECISION-Panc：胰腺癌的下一代治疗开发平台
Clin Oncol (R Coll Radiol). 2020 Jan;32(1):1-4. doi: 10.1016/j.clon.2019.07.011. Epub 2019 Aug 2.
2
Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study.评估胰腺癌患者中癌症易感性基因的种系突变：一项单中心研究。
Mol Med. 2023 Jan 30;29(1):14. doi: 10.1186/s10020-023-00600-1.
3
Overexpression of circRNA chr7:154954255-154998784+ in cancer-associated pancreatic stellate cells promotes the growth and metastasis of pancreatic cancer by targeting the miR-4459/KIAA0513 axis.环状RNA chr7:154954255-154998784+在癌症相关胰腺星状细胞中的过表达通过靶向miR-4459/KIAA0513轴促进胰腺癌的生长和转移。
Am J Transl Res. 2020 Sep 15;12(9):5048-5063. eCollection 2020.
4
Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling.冬凌草甲素通过调节谷胱甘肽S-转移酶π（GST pi）和肺耐药蛋白（LRP）/1 细胞外调节蛋白激酶（ERK）/应激活化蛋白激酶（JNK）信号通路克服吉西他滨耐药的PANC-1/Gem细胞。
Onco Targets Ther. 2019 Jul 17;12:5751-5765. doi: 10.2147/OTT.S208924. eCollection 2019.
5
Long non-coding RNA suppresses growth and epithelial-mesenchymal transition by inhibiting Wnt/-catenin signaling pathway in human pancreatic cancer PANC-1 cells: Insights from and studies.长非编码 RNA 通过抑制 Wnt/-catenin 信号通路抑制人胰腺癌细胞 PANC-1 的生长和上皮-间充质转化：来自 和 研究的见解。
Acta Pharm. 2024 Mar 30;74(1):131-147. doi: 10.2478/acph-2024-0009. Print 2024 Mar 1.
6
Dendritic cells loaded with pancreatic Cancer Stem Cells (CSCs) lysates induce antitumor immune killing effect in vitro.负载胰腺癌干细胞（CSCs）裂解物的树突状细胞在体外诱导抗肿瘤免疫杀伤作用。
PLoS One. 2014 Dec 18;9(12):e114581. doi: 10.1371/journal.pone.0114581. eCollection 2014.
7
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.组蛋白甲基转移酶G9a作为克服胰腺癌吉西他滨耐药性的治疗靶点。
Oncotarget. 2016 Sep 20;7(38):61136-61151. doi: 10.18632/oncotarget.11256.
8
Natural quinones induce ROS-mediated apoptosis and inhibit cell migration in PANC-1 human pancreatic cancer cell line.天然醌类化合物可诱导活性氧介导的细胞凋亡，并抑制人胰腺癌细胞系PANC-1的细胞迁移。
J Biochem Mol Toxicol. 2022 May;36(5):e23008. doi: 10.1002/jbt.23008. Epub 2022 Mar 7.
9
Molecular Subtyping and Precision Medicine for Pancreatic Cancer.胰腺癌的分子分型与精准医学
J Clin Med. 2021 Jan 4;10(1):149. doi: 10.3390/jcm10010149.
10
Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells.未成熟和 TLR4 预激活脂肪间充质干细胞对胰腺导管腺癌细胞的抗肿瘤作用。
Cancer Med. 2024 Jan;13(2):e6964. doi: 10.1002/cam4.6964.

引用本文的文献

1
Treatment of pancreatic cancer in 2022.2022年胰腺癌的治疗
Camb Prism Precis Med. 2023 Feb 3;1:e14. doi: 10.1017/pcm.2023.2. eCollection 2023.
2
Prevalence of mutations in common tumour types in Northern England and comparable utility of national and international Trial Finders.英格兰北部常见肿瘤类型突变的流行情况以及国家和国际试验发现者的可比效用。
J Cancer Res Clin Oncol. 2023 Dec;149(18):16355-16363. doi: 10.1007/s00432-023-05365-y. Epub 2023 Sep 13.
3
Management of Patients With Pancreatic Cancer Using the "Right Track" Model.
使用“正确轨道”模型管理胰腺癌患者。
Oncologist. 2023 Jul 5;28(7):584-595. doi: 10.1093/oncolo/oyad080.
4
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer.分子亚型对胰腺癌病理分期的影响。
Ann Surg. 2023 Feb 1;277(2):e396-e405. doi: 10.1097/SLA.0000000000005050. Epub 2023 Jan 10.
5
The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer.肿瘤微环境的异质性作为胰腺癌发生、发展及治疗反应的关键决定因素
Cancers (Basel). 2021 Sep 30;13(19):4932. doi: 10.3390/cancers13194932.
6
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go.精准医学时代的转化研究：我们所处的位置与前行的方向。
J Pers Med. 2021 Mar 18;11(3):216. doi: 10.3390/jpm11030216.
7
Current State of "Omics" Biomarkers in Pancreatic Cancer.胰腺癌中“组学”生物标志物的现状
J Pers Med. 2021 Feb 14;11(2):127. doi: 10.3390/jpm11020127.
8
Molecular Subtyping and Precision Medicine for Pancreatic Cancer.胰腺癌的分子分型与精准医学
J Clin Med. 2021 Jan 4;10(1):149. doi: 10.3390/jcm10010149.
9
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine.重塑精准医学时代的胰腺癌术前治疗。
Ann Oncol. 2021 Feb;32(2):183-196. doi: 10.1016/j.annonc.2020.11.013. Epub 2020 Nov 26.
10
Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities.迈向精准肿瘤学治疗胰腺癌：现实世界的挑战与机遇。
Genes (Basel). 2020 Sep 21;11(9):1098. doi: 10.3390/genes11091098.